BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115
Clinical trial NCT01597622 · COMPLETED
Trial details
- NCT number
- NCT01597622
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-11
- Primary completion
- 2018-09-13
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.